Safety and Tolerability Study of 2 Dose Level of ArikayceTM in Patients with Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa - Insmed
- Study Results - ClinicalTrials.gov. Accessed January 17, 2021 at: